This ELISA incorporates some improvements over the Cat. #F050 and F050H kits and is designed to better detect the newer, unnatural constructs of Protein A such as the MabSelect SuReTM ligand sold by GE Healthcare. If you are using a recombinant form of Protein A with very significant structural differences from natural Protein A such as MabSelect SuReTM you should use the Catalog #F400 kit.
Since this kit has been released, 2 newer Protein A assays, known as Mix-N-Go methods, have been developed. These new methods eliminate the sample boiling and centrifugation steps. Instead, a special sample treatment reagent is used that allows for accurate detection of Protein A in the presence of your sample antibody. The Cat. #F600 kit uses standards calibrated against natural and conserved recombinant forms of Protein A. The Cat. #F610 kit uses standards calibrated to unnatural constructs of Protein A such as GE Healthcare's MabSelect SuReTM.
PNPP Liquid Substrate F008 For use with Alk Phos in ELISA, 100mL
PNPP Liquid Substrate F10008 For use with Alk Phos in ELISA, 1L
TMB Liquid Substrate F027 For use with HRP in ELISA, 100mL
TMB Liquid Substrate F100027 For use with HRP in ELISA, 1L
TMB Liquid Substrate F129 For use with HRP in Western Blot, 100mL
TMB Liquid Substrate F100029 For use with HRP in Western Blot, 1L
BCIP/NBT Liquid Substrate F064 For use with Alk Phos in WB, 1 reagent, 100mL
BCIP/NBT Liquid Substrate F00064 For use with Alk Phos in WB, 1 reagent, 1L
Sample Dilution Buffers
Sample Dilution Buffer, 1L, 100mL, 500mL I028 I028-100 I028-500 For use with BHK, E.coli, CHO, CHO-CM, Human IgG's, HSA, hTransferrin, HEK 293, Insulin, L.lactic, Mouse IgG's, Pichia pastoris, S.cerevisiae, Protein A, Vero cell ELISA kits
A549 Sample Diluent, 100mL , 500mL F233A-100 F233A-500 For use with A549 HCP ELISA kit
BSA Sample Dilution Buffer, 1L , 100mL , 500mL F031A / F031A-100 / F031A-500 For use with BSA, Bovine IgG, Bovine Plasma Proteins and Bovine Transferrin ELISA kits
Goat IgG Dilution Buffer, 1L , 100mL , 500mL F213A /F213A-100 / F213A-500 For use with Goat IgG ELISA kit
Goat Milk Diluent Buffer, 1L , 100mL r, 500mL F243A /F243A-100 /F243A-500 For use with Goat Milk Proteins ELISA kit
NS/0 Sample Dilution Buffer, 1L ,100mL ,500mL F223A / F223A-100 /F223A-500 For use with NS/0 HCP ELISA kit
SP2/0 Sample Dilution Buffer, 1L , 100mL , 500mL F183A / F183A-100 / F183A-500 For use with SP2/0 HCP ELISA kit
Immunogenicity Products
Passive Coated Immunogenicity Kit IM10 Kit for immunogenicity testing
Biotinylated Antigen Coated Immunogenicity Kit IM20 Kit for immunogenicity testing
Biotinylation Kit IM30
Human Immunoglobulin Screening Kit IM40 Kit for immunogenicity testing
Human IgG Subclass Kit IM50 Kit for immunogenicity testing
Substrate Kit IM109 TMB & Stop Solution for ELISA, 50mL
Coatingate Buffer, 1L IM101 For immunogenicity testing
Conjugate Diluent, 1L IM103 For immunogenicity testing
Conjugate Diluent, 500mL IM103-500 For immunogenicity testing
Sample Diluent, 500mL IM104 For immunogenicity testing
FG Blocker, 1L IM107 For immunogenicity testing
BSA Antigen, 1mg/mL IM112 For immunogenicity testing
Bovine IgG Antigen, 1mg/mL IM113 For immunogenicity testing
Bovine Transferrin Antigen, 1mg/mL IM114 For immunogenicity testing
CHO HCP Antigen, 1mg/mL IM115 For immunogenicity testing
E. coli HCP Antigen, 1mg/mL IM116 For immunogenicity testing
Goat IgG Antigen, 1mg/mL IM117 For immunogenicity testing
HSA Antigen, 1mg/mL IM118 For immunogenicity testing
Human IgD Antigen, 1mg/mL IM141 For immunogenicity testing
Human Transferrin Antigen, 1mg/mL IM119 For immunogenicity testing
Insulin Antigen, 1mg/mL IM121 For immunogenicity testing
Mouse IgG Antigen, 1mg/mL IM122 For immunogenicity testing
NS/0 HCP Antigen, 1mg/mL IM123 For immunogenicity testing
SP2/0 HCP Antigen, 1mg/mL IM125 For immunogenicity testing
Gyros Kits-discontinued
CHO 3G HCP G550 For use on the Gyros xP workstation, 560 tests
CHO 3G HCP G550-1 For use on the Gyros xP workstation, 112 tests
E.coli HCP G410 For use on the Gyros xP workstation, 560 tests
E.coli HCP G410-1 For use on the Gyros xP workstation, 112 tests
Protein A G400 For use on the Gyros xP workstation, 560 tests
Protein A G400-1 For use on the Gyros xP workstation, 112 tests
DNA Kits
DNA Extracton in Wells D100W 96 tests in a deep well microtiter plate
DNA Extraction in Tubes D100T 50 tests in microfuge tubes
Residual CHO Host Cell kit in Wells D550W 96 tests in a deep well microtiter plate
Residual CHO Host Cell kit in Tubes D550T 50 tests in microfuge tubes
CHO Amplification kit in Wells D555W 96 tests in a deep well microtiter plate
CHO Amplification kit in Tubes D555T 50 tests in microfuge tubes
Residual Ecoli Host Cell kit in Wells D410W 96 tests in a deep well microtiter plate
Residual Ecoli Host Cell kit in Tubes D410T 50 tests in microfuge tubes
E.coli Amplification kit in Wells D415W 96 tests in a deep well microtiter plate
E.coli Amplification kit in Tubes D415T 50 tests in microfuge tubes
Residual NS/0 Host Cell kit in Wells D220W 96 tests in a deep well microtiter plate
Residual NS/0 Host Cell kit in Tubes D220T 50 tests in microfuge tubes
Miscellaneous Reagents & Components
Deep Well Extraction Plate w/Sealing Mat D102 5 plates
[1]. Cozza G, et al. Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. J Med Chem. 2006 Apr 20;49(8):2363-6.
[2]. Rizk HA, et al. Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats. J Biochem Mol Toxicol. 2017 Dec;31(12).
[3]. Ahire V, et al. Ellagic Acid Enhances Apoptotic Sensitivity of Breast Cancer Cells to γ-Radiation. Nutr Cancer. 2017 Aug-Sep;69(6):904-910.
规格
10mg 50mg
是一种抗氧化剂,为有效的,ATP 竞争性的 CK2 抑制剂。
使用本产品应用案例:
文章:The protective effect of Ellagic acid (EA) in osteoarthritis: An in vitro and in vivo study. Biomed Pharmacother. 2020 May;125:109845.
作者:Lin Z, Lin C, Fu C, Lu H, Jin H, Chen Q, Pan J.
doi: 10.1016/j.biopha.2020.109845. Epub 2020 Feb 12. PMID: 32058211.
摘要:
骨关节炎(OA)是一种进行性关节疾病,其主要特征是关节软骨的退化和破坏。鞣花酸 (EA) 是一种在浆果和坚果中发现的天然多酚,已显示出有效的抗炎作用,然而,它对 OA 的作用和潜在机制却很少被系统地阐明。在这项研究中,我们在体外和体内实验中报告了鞣花酸 (EA) 在 OA 进展中的抗炎作用。体外研究,IL-1β 诱导的诱导型一氧化氮合酶 (iNOS)、环氧合酶-2 (COX-2)、一氧化氮 (NO)、肿瘤坏死因子-α (TNF-α)、前列腺素 E2(PGE2) 的表达, 和白细胞介素 6 (IL-6) 被鞣花酸 (EA) 抑制。此外,鞣花酸 (EA) 下调 IL-1β 刺激的基质金属蛋白酶 13 (MMP-13) 和血小板反应蛋白基序 5 (ADAMTS-5),同时上调 II 型胶原蛋白和聚集蛋白聚糖。从机制上讲,我们发现鞣花酸 (EA) 抑制 IL-1β 诱导的软骨细胞中的核因子 kappa B (NF-κB) 信号传导。 DMM模型也显示了鞣花酸(EA)诱导的OA发展保护作用。总之,我们的数据表明鞣花酸 (EA) 可作为 OA 治疗的潜在药物。
方案:
Cell viability
Firstly, passages 3 chondrocytes were seeded into 96-well plates (5,000 cells/well) and incubated for 24 h. Then, the cells incubated with a concentration gradient (12.5, 25, 50 μM) of Ellagic acid (EA) for 24 h and 48 h when the cells reached a confluency of 90 %–95 %. Next, half the cells were incubated in IL-1β (10 ng/ml) for the next 24 h.Finally, 10 μl CCK-8 solution was added to each well for 2 h and the optical density was observed at 450 nm with a spectrophotometer . All experiments were repeated three times.
Animals
The mouse osteoarthritis model was established by surgical destabilization of the medial meniscus (DMM). In brief, mice were anesthetized with intraperitoneal injection of 2 % (w/v) pentobarbital (40 mg kg−1,) and then the joint capsule of right knee medial to the patellar tendon was excised. The medial meniscotibial ligaments were cut with microsurgical scissors. Surgery consisting of an arthrotomy was also performed on the left knee joint of mice and the joint was used as the sham group. Ultimately, all of the mice were separated into three groups randomly (n = 15 in each): a control group (sham-operated), OA group (OA) and OA treated with Ellagic acid (EA) group.